|Articles|June 26, 2008

HIV drug Aptivus gains new indication approval for kids

Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.

Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’


Related to this article

Back-to-School Health, OTC Options, Fall OTC Products
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.